Beta-blockers in atrial fibrillation—trying to make sense of unsettling results. Issue 2 (7th February 2023)

• Record Type: Journal Article
• Authors: Meyer, Markus; Lustgarten, Daniel
• Is Part Of: Europace. Volume 25:Issue 2(2023)
• Page Start: 260
• Page End: 262
• Publication Date: 2023-02-07
• Subjects: Heart failure with preserved ejection fraction -- Atrial fibrillation -- Beta-blockers -- Diastolic dysfunction; Arrhythmia -- Treatment -- Periodicals; Cardiac pacing -- Periodicals; Catheter ablation -- Periodicals; Heart -- Physiology -- Periodicals; Electrophysiology -- Periodicals; 617.4120645
• DOI: 10.1093/europace/euad010
• Languages: English
• ISSNs: 1099-5129

Abstract

Abstract: Atrial fibrillation is closely associated with heart failure and adversely affects outcomes. Beta-blockers are strongly recommended to avoid rapid ventricular conduction and tachycardia-induced cardiomyopathy. In this Viewpoint article, we discuss an emerging body of evidence that questions beta-blockers as a preferred rate-control therapy in patients with atrial fibrillation.